Wire Stories
-
813Mitsubishi Electric Announces End of Production of TFT-LCD Modules
TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will end the production of TFT-LCD modules manufactured by its wholly owned...
-
801
AVITA Medical Limited Proposed Redomiciliation to the United States of America – Results of Scheme Meeting
VALENCIA, Calif. & MELBOURNE, Australia–(BUSINESS WIRE)–AVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that shareholders today voted in...
-
926
BORN Group Extends Its Partnership With Akeneo Globally, to Augment Its Experience Management & Enterprise Commerce Offerings
Tapped as BORN’s exclusive PIM partner, Akeneo’s Product Experience Management (PXM) capabilities well complement BORN’s award-winning digital omnichannel enterprise commerce and customer...
-
819
Gunfire Reborn, a FPS+Roguelite game, is on Steam �Top Sellers�
HONG KONG–(BUSINESS WIRE)–Recently, FPS+Roguelite game Gunfire Reborn developed by Duoyi (Hong Kong) Interactive starts Early Access on Steam. Upon release, it receives...
-
865
New Phase II data indicate regimen of Truxima� (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) may be well tolerated and effective in relapsed/refractory aggressive B-cell lymphoma
Data from a Phase II trial show a regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) was well tolerated in people...
-
765
BrainChip Successfully Launches the Akida Early Access Program
ALISO VIEJO, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN), a leading provider of Ultra-Low Power, high performance AI technology, today announced an Early...
-
771
AVITA Medical Limited Proposed Redomiciliation to the United States of America – Chair�s Address to Scheme Meeting
VALENCIA, Calif. & MELBOURNE, Australia–(BUSINESS WIRE)–In accordance with ASX Listing Rule 3.13.3, AVITA Medical Limited ACN 058 466 523 (Company) is pleased...
-
785
Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. ( “Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive...
-
881
American Express Receives Clearance to Begin Processing Local Transactions in Mainland China
Company becomes the first foreign payments network to be granted a clearing license in mainland China BEIJING–(BUSINESS WIRE)–American Express (NYSE: AXP) announced...
-
943
Dr. Reddy’s Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to...
